Silencing of circ_0000205 mitigates interleukin-1β-induced apoptosis and extracellular matrix degradation in chondrocytes via targeting miR-766-3p/ADAMTS5 axis.
ADAMTS5
Osteoarthritis
circ_0000205
miR-766-3p
Journal
Innate immunity
ISSN: 1753-4267
Titre abrégé: Innate Immun
Pays: United States
ID NLM: 101469670
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
entrez:
28
4
2022
pubmed:
29
4
2022
medline:
3
5
2022
Statut:
ppublish
Résumé
The aim of this study was to explore the role of hsa_circRNA_0000205 (circ_0000205) in chondrocyte injury in osteoarthritis (OA) and the underlying mechanism. Expression of circ_0000205, microRNA (miR)-766-3p and a disintegrin and metalloproteinase with thrombospondin motif (ADAMTS)-5 was detected by quantitative real time (qRT)-polymerase chain reaction (PCR) and Western blot assays. Cell proliferation, apoptosis, and extracellular matrix (ECM) synthesis were examined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and 5-ethynyl-2-deoxyuridine assays, flow cytometry, and qRT-PCR and Western blot assays. The target relationship between miR-766-3p and circ_0000205 or ADAMTS5 was confirmed by luciferase reporter assay and RNA immunoprecipitation. IL-1β treatment could attenuate cell viability of primary chondrocytes and proliferating cell nuclear antigen (PCNA) and collagen II type alpha-1 (COL2A1) levels, and elevate apoptosis rate and cleaved caspase-3, ADAMTS5 and matrix metalloproteinase-13 (MMP13) levels, suggesting that IL-1β induced chondrocyte apoptosis and ECM degradation. Expression of circ_0000205 was up-regulated in OA tissues and IL-1β-induced primary chondrocytes, accompanied with miR-766-3p down-regulation and ADAMTS5 up-regulation. Knockdown of circ_0000205 could mitigate IL-1β-induced above effects and improve cell proliferation. Moreover, both depleting miR-766-3p and promoting ADAMTS5 could partially counteract circ_0000205 knockdown roles in IL-1β-cultured primary chondrocytes. Notably, circ_0000205 was verified as a sponge for miR-766-3p via targeting, and ADAMTS5 was a direct target for miR-766-3p. Silencing circ_0000205 could protect chondrocytes from IL-1β-induced proliferation reduction, apoptosis, and ECM degradation by targeting miR-766-3p/ADAMTS5 axis.
Identifiants
pubmed: 35484121
doi: 10.1177/17534259221077078
pmc: PMC9058376
doi:
Substances chimiques
Interleukin-1beta
0
MIRN766 microRNA, human
0
MicroRNAs
0
RNA, Circular
0
ADAMTS5 Protein
EC 3.4.24.-
ADAMTS5 protein, human
EC 3.4.24.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
79-90Références
Int J Genomics. 2017;2017:1746426
pubmed: 28758108
Curr Opin Clin Nutr Metab Care. 2003 May;6(3):289-93
pubmed: 12690261
Arthritis Rheumatol. 2014 Apr;66(4):969-78
pubmed: 24757148
Yonsei Med J. 2018 May;59(3):349-355
pubmed: 29611396
J Cell Biochem. 2018 Mar;119(3):2579-2587
pubmed: 28980719
J Biotechnol. 2016 Nov 20;238:42-51
pubmed: 27671698
Clin Orthop Relat Res. 2016 Aug;474(8):1886-93
pubmed: 26872913
Cell Physiol Biochem. 2017;44(1):38-52
pubmed: 29241192
Int J Exp Pathol. 2020 Feb;101(1-2):4-20
pubmed: 32219922
Nature. 2005 Mar 31;434(7033):648-52
pubmed: 15800625
Arthritis Rheum. 2012 Jun;64(6):1909-19
pubmed: 22143896
Cell Signal. 2019 Jan;53:212-223
pubmed: 30312659
Matrix Biol. 2018 Oct;71-72:225-239
pubmed: 29885460
Prim Care. 2013 Dec;40(4):821-36, vii
pubmed: 24209720
Int J Mol Med. 2019 Aug;44(2):630-642
pubmed: 31198977
Osteoarthritis Cartilage. 2015 Aug;23(8):1254-66
pubmed: 25800415
Biotechnol Lett. 2021 Apr;43(4):791-802
pubmed: 33404903
Biosci Rep. 2018 Oct 31;38(5):
pubmed: 30279209
Clin Orthop Surg. 2010 Mar;2(1):1-7
pubmed: 20190994
Theranostics. 2021 Jan 1;11(4):1877-1900
pubmed: 33408787
Aging (Albany NY). 2020 Oct 25;12(20):20163-20183
pubmed: 33099538
Eur Cell Mater. 2006 Oct 26;12:49-56; discussion 56
pubmed: 17068722
Wiley Interdiscip Rev RNA. 2020 Jul;11(4):e1584
pubmed: 31925936
Bone Joint Res. 2019 Aug 02;8(7):290-303
pubmed: 31463037
J Mol Med (Berl). 2016 Jul;94(7):771-85
pubmed: 27067395
J Cell Mol Med. 2021 Jan;25(1):120-131
pubmed: 33205602
Onco Targets Ther. 2017 May 05;10:2461-2471
pubmed: 28503069
Front Cell Dev Biol. 2020 Oct 07;8:594135
pubmed: 33117820
N Engl J Med. 2010 Oct 14;363(16):1521-31
pubmed: 20942668
Biochem J. 2016 Jan 1;473(1):e1-4
pubmed: 26657033
J Biol Chem. 2002 Jun 21;277(25):22201-8
pubmed: 11956193
Drug Des Devel Ther. 2020 Jul 07;14:2645-2655
pubmed: 32753846
Nature. 2005 Mar 31;434(7033):644-8
pubmed: 15800624
Arthritis Rheum. 2012 Jun;64(6):1697-707
pubmed: 22392533
Osteoarthritis Cartilage. 2008 Nov;16(11):1413-20
pubmed: 18485748
Mol Ther Nucleic Acids. 2021 May 08;24:856-867
pubmed: 34026329
Clin Geriatr Med. 2010 Aug;26(3):371-86
pubmed: 20699160